busulfan has been researched along with cycloserine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bi, Y; Bongarzone, ER; Hu, P; Kafri, T; Li, Y; Miller, R; Moore, D; Nikolaishvili-Feinberg, N; Pan, D; Sands, MS; Scesa, G | 1 |
1 review(s) available for busulfan and cycloserine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for busulfan and cycloserine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.
Topics: Animals; Antigens, CD; Antimetabolites; Brain; Busulfan; Cell Line, Transformed; Cycloserine; Disease Models, Animal; Female; Fibroblasts; Galactosylceramidase; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukodystrophy, Globoid Cell; Receptor, IGF Type 2; Receptors, Somatomedin | 2016 |